IGF-1R expression is associated with HPV-negative status and adverse survival in head and neck squamous cell cancer
Head and neck squamous cell carcinomas (HNSCC) are treated with surgery, radiotherapy and cisplatin-based chemotherapy, but survival from locally-advanced disease remains poor, particularly in patients whose tumors are negative for Human papillomavirus (HPV). Type 1 IGF receptor (IGF-1R) is known to...
Main Authors: | Dale, OT, Aleksic, T, Shah, KA, Han, C, Mehanna, H, Rapozo, DCM, Sheard, JDH, Goodyear, P, Upile, NS, Robinson, M, Jones, TM, Winter, S, Macaulay, VM |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Oxford University Press
2015
|
Similar Items
-
Insulin like growth factor receptor 1 (IGF-1R) and radiotherapy resistance in laryngeal squamous cell cancer (LSCC)
by: Qureishi, A, et al.
Published: (2018) -
Therapeutic targeting of the IGF axis
by: Osher, E, et al.
Published: (2019) -
Radioresistant laryngeal cancers upregulate type 1 IGF receptor and exhibit increased cellular dependence on IGF and EGF signalling
by: Qureishi, A, et al.
Published: (2019) -
Role of IGF2BPs in head and neck squamous cell carcinoma
by: Kainan Wu, et al.
Published: (2022-09-01) -
Radioimmunotherapy in HPV-Associated Head and Neck Squamous Cell Carcinoma
by: Xin Zhou, et al.
Published: (2022-08-01)